Atlanta Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-437,951
| Closed | -$21.9M | – | 173 |
|
|
2021
Q3 | $21.9M | Sell |
437,951
-16,454
| -4% | -$824K | 0.08% | 164 |
|
|
2021
Q2 | $28.6M | Buy |
454,405
+1,808
| +0.4% | +$114K | 0.1% | 155 |
|
|
2021
Q1 | $42.1M | Buy |
452,597
+5,613
| +1% | +$522K | 0.15% | 137 |
|
|
2020
Q4 | $40.1M | Buy |
446,984
+10,015
| +2% | +$897K | 0.14% | 136 |
|
|
2020
Q3 | $45.2M | Sell |
436,969
-223,883
| -34% | -$23.1M | 0.19% | 125 |
|
|
2020
Q2 | $52.3M | Sell |
660,852
-59,432
| -8% | -$4.7M | 0.22% | 111 |
|
|
2020
Q1 | $41.7M | Buy |
720,284
+138,804
| +24% | +$8.03M | 0.22% | 105 |
|
|
2019
Q4 | $31.4M | Sell |
581,480
-19,083
| -3% | -$1.03M | 0.13% | 125 |
|
|
2019
Q3 | $31.4M | Buy |
600,563
+88,306
| +17% | +$4.62M | 0.14% | 121 |
|
|
2019
Q2 | $24.7M | Buy |
512,257
+44,789
| +10% | +$2.16M | 0.11% | 131 |
|
|
2019
Q1 | $23.6M | Buy |
467,468
+204,807
| +78% | +$10.3M | 0.11% | 132 |
|
|
2018
Q4 | $15.6M | Buy |
+262,661
| New | +$15.6M | 0.09% | 143 |
|